Wolfgang Voightlander

Title: The Innovations of Wolfgang Voightlander

Introduction

Wolfgang Voightlander, an accomplished inventor based in Viernheim, Germany, has made notable contributions to the field of cardiology through his innovative research. With a patent to his name, he exemplifies the spirit of discovery and innovation that drives the medical field forward.

Latest Patents

Wolfgang Voightlander's most significant patent is titled "Cardioactive 12-epi-digoxin and derivatives thereof." This groundbreaking invention pertains to 12-Epi-digoxins, specifically of the formula ##STR1##, wherein R1 and R2 can independently be hydrogen or a lower alkanoyl or alkyl radical. This invention showcases his commitment to advancing therapeutic options in cardiac care.

Career Highlights

Voightlander is associated with Boehringer Mannheim GmbH, a reputable company known for its pioneering work in pharmaceuticals and diagnostics. His role at the company has allowed him to explore new frontiers in drug development, particularly in the cardiology sector.

Collaborations

Throughout his career, Wolfgang Voightlander has had the privilege of collaborating with talented professionals like Fritz Kaiser and Wolfgang Schaumann. These partnerships have not only enriched his work but have also fostered an environment of collective innovation and problem-solving.

Conclusion

Wolfgang Voightlander’s contributions to cardiovascular medicine through his patent highlight his role as a significant inventor in the field. His work continues to inspire both current and future generations of researchers and inventors.